Literature DB >> 30992796

Disease pathways and molecular mechanisms of nonalcoholic steatohepatitis.

Kara Wegermann1, Anna Mae Diehl1, Cynthia A Moylan1,2.   

Abstract

Entities:  

Year:  2018        PMID： 30992796      PMCID： PMC6385948          DOI： 10.1002/cld.709

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  4 in total

1.  New Rat Model of Advanced NASH Mimicking Pathophysiological Features and Transcriptomic Signature of The Human Disease.

Authors:  Raquel Maeso-Díaz; Zoe Boyer-Diaz; Juan José Lozano; Martí Ortega-Ribera; Carmen Peralta; Jaime Bosch; Jordi Gracia-Sancho
Journal:  Cells       Date:  2019-09-10       Impact factor: 6.600

Review 2.  A Structured Literature Review of the Epidemiology and Disease Burden of Non-Alcoholic Steatohepatitis (NASH).

Authors:  Manca Povsic; On Yee Wong; Richard Perry; Juliana Bottomley
Journal:  Adv Ther       Date:  2019-05-07       Impact factor: 3.845

Review 3.  Harnessing Muscle-Liver Crosstalk to Treat Nonalcoholic Steatohepatitis.

Authors:  Manu V Chakravarthy; Mohammad S Siddiqui; Mikael F Forsgren; Arun J Sanyal
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-23       Impact factor: 5.555

4.  Cholesterol Accumulation as a Driver of Hepatic Inflammation Under Translational Dietary Conditions Can Be Attenuated by a Multicomponent Medicine.

Authors:  Andrea M Mueller; Robert Kleemann; Eveline Gart; Wim van Duyvenvoorde; Lars Verschuren; Martien Caspers; Aswin Menke; Natascha Krömmelbein; Kanita Salic; Yvonne Burmeister; Bernd Seilheimer; Martine C Morrison
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-18       Impact factor: 5.555
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.